Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GLIMEPIRIDE Cause Renal failure? 124 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Renal failure have been filed in association with GLIMEPIRIDE (Glimepiride). This represents 2.2% of all adverse event reports for GLIMEPIRIDE.

124
Reports of Renal failure with GLIMEPIRIDE
2.2%
of all GLIMEPIRIDE reports
28
Deaths
89
Hospitalizations

How Dangerous Is Renal failure From GLIMEPIRIDE?

Of the 124 reports, 28 (22.6%) resulted in death, 89 (71.8%) required hospitalization, and 20 (16.1%) were considered life-threatening.

Is Renal failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GLIMEPIRIDE. However, 124 reports have been filed with the FAERS database.

What Other Side Effects Does GLIMEPIRIDE Cause?

Hypoglycaemia (1,403) Blood glucose increased (446) Acute kidney injury (339) Drug ineffective (339) Diarrhoea (257) Blood glucose decreased (232) Lactic acidosis (219) Glycosylated haemoglobin increased (214) Diabetes mellitus inadequate control (213) Hypoglycaemic coma (187)

What Other Drugs Cause Renal failure?

OMEPRAZOLE (14,721) ESOMEPRAZOLE (14,633) LANSOPRAZOLE (12,509) PANTOPRAZOLE (11,543) EMTRICITABINE\TENOFOVIR DISOPROXIL (8,618) DEXLANSOPRAZOLE (6,618) TENOFOVIR DISOPROXIL (6,388) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,596) RABEPRAZOLE (3,135) LENALIDOMIDE (2,729)

Which GLIMEPIRIDE Alternatives Have Lower Renal failure Risk?

GLIMEPIRIDE vs GLIMEPIRIDE\ROSIGLITAZONE GLIMEPIRIDE vs GLIPIZIDE GLIMEPIRIDE vs GLIVEC GLIMEPIRIDE vs GLOFITAMAB GLIMEPIRIDE vs GLOFITAMAB-GXBM

Related Pages

GLIMEPIRIDE Full Profile All Renal failure Reports All Drugs Causing Renal failure GLIMEPIRIDE Demographics